ResearcherUniversity of ChicagoActive in the last 2 years

Christine M. Drogan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9927-9739; OpenAlex author ID A5031958424. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 13

Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 4

REGENERATE Generates Insights Regarding Equitable Assessment of Black and Latin Subjects at Increased Genetic Risk for Pancreatic Cancer. Co-author DOI 10.1007/s10620-025-09220-7 ↗
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Co-author DOI 10.1002/cncr.35383 ↗
Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2023-109539 ↗
Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/po.22.00196 ↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sonia S. Kupfer · 3 shared papers, 2023–2024 · strength 0.68
Hedy Lee Kindler · 1 shared paper, 2023 · strength 0.26
- Paper Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma. DOI 10.1200/po.22.00196 ↗
Denis Nguyen · 1 shared paper, 2024 · strength 0.26
- Paper Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma. DOI 10.1136/jmg-2023-109539 ↗
Jessica N. Everett · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Elana Levinson · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Heather Hampel · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Marta Puzzono · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Eve Karloski · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Beth Dudley · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Giulia Martina Cavestro · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Diane M. Simeone · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Randall E. Brand · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗
Fay Kastrinos · 1 shared paper, 2024 · strength 0.15
- Paper The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of… DOI 10.1002/cncr.35383 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.